Cancer Immunology Research,
Journal Year:
2024,
Volume and Issue:
12(8), P. 1039 - 1057
Published: April 19, 2024
NK
cells
can
be
rapidly
activated
in
response
to
cytokines
during
host
defense
against
malignant
or
viral
infection.
However,
it
remains
unclear
what
mechanisms
precisely
and
regulate
the
expression
of
a
large
number
genes
involved
activating
cells.
In
this
study,
we
discovered
that
NK-cell
N6-methyladenosine
(m6A)
methylation
levels
were
upregulated
upon
short-term
activation
repressed
tumor
microenvironment
(TME).
Deficiency
methyltransferase-like
3
(METTL3)
METTL14
moderately
influenced
homeostasis,
while
double-knockout
METTL3/14
more
significantly
impacted
maturation,
antitumor
immunity.
This
suggests
cooperative
role
METTL3
regulating
development
effector
functions.
Using
methylated
RNA
immunoprecipitation
sequencing,
demonstrated
functions,
such
as
Prf1
Gzmb,
directly
modified
by
m6A
methylation.
Furthermore,
inhibiting
mTOR
complex
1
prevented
from
increasing
when
activated,
could
restored
S-adenosylmethionine
supplementation.
Collectively,
have
unraveled
crucial
roles
for
rapid
mRNA
downstream
1-S-adenosylmethionine
signal
axis
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Feb. 14, 2024
Abstract
Skeletal
system
disease
(SSD)
is
defined
as
a
class
of
chronic
disorders
skeletal
with
poor
prognosis
and
causes
heavy
economic
burden.
m6A,
methylation
at
the
N6
position
adenosine
in
RNA,
reversible
dynamic
modification
posttranscriptional
mRNA.
Evidences
suggest
that
m6A
modifications
play
crucial
role
regulating
biological
processes
all
kinds
diseases,
such
malignancy.
Recently
studies
have
revealed
most
abundant
epigentic
modification,
involved
progression
SSD.
However,
function
SSD
not
fully
illustrated.
Therefore,
make
clear
relationship
between
pathogenesis
might
provide
novel
sights
for
prevention
targeted
treatment
This
article
will
summarize
recent
advances
regulation
SSD,
including
osteoporosis,
osteosarcoma,
rheumatoid
arthritis
osteoarthritis,
discuss
potential
clinical
value,
research
challenge
future
prospect
Journal of Cellular and Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
29(5)
Published: March 1, 2025
Osteoarthritis,
osteoporosis,
and
osteosarcoma
are
prevalent
osseous
pathologies
associated
with
the
aberrant
functionality
of
chondrocytes,
osteoclasts,
osteoblasts,
respectively.
These
conditions
frequently
exhibit
therapeutic
resistance
possess
a
high
mortality
risk,
thus
representing
substantial
health
threats.
To
mitigate
these
concerns,
it
is
imperative
to
investigate
novel
mechanistic
insights.
Methyltransferase-like
3
(METTL3)
pivotal
in
disorders
by
modulating
gene
expression
via
N6-methyladenosine
(m6A)
modifications
on
RNA,
thereby
impacting
cellular
processes.
Although
considerable
research
has
elucidated
METTL3's
involvement
diseases,
systematic
review
essential
summarise
findings
evaluate
significance.
This
endeavours
aggregate
examine
contemporary
studies
elucidate
role
bone
its
clinical
implications.
We
propose
that
METTL3
constitutes
risk
mediating
m6A
both
mRNAs
non-coding
RNAs,
suggesting
may
serve
as
critical
diagnostic
biomarker
target.
In
conclusion,
this
provides
an
extensive
analysis
correlation
osteoarthritis,
osteosarcoma,
offering
valuable
perspectives
extant
serving
reference
for
researchers
engaged
basic
translational
studies.
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: May 6, 2025
Elucidating
the
molecular
mechanisms
underlying
orthopedic
diseases
is
crucial
for
guiding
therapeutic
strategies
and
developing
innovative
interventions.
N6-methyladenosine
(m6A)-an
epitranscriptomic
modification-has
emerged
as
a
key
regulator
of
cellular
fate
tissue
homeostasis.
Specifically,
m6A
plays
pivotal
role
in
several
RNA
biological
processes
such
precursor
splicing,
3'-end
processing,
nuclear
export,
translation,
stability.
Recent
advancements
indicate
that
methylation
regulates
stem
cell
proliferation
osteogenic
differentiation
by
modulating
various
signaling
pathways.
Extensive
research
has
shown
abnormalities
contribute
significantly
to
onset
progression
osteoporosis
(OP),
osteoarthritis
(OA),
rheumatoid
arthritis
(RA),
bone
tumors.
This
review
aims
summarize
proteases
involved
their
functions.
The
detailed
which
marrow
mesenchymal
cells
(BMSCs)
through
direct
indirect
ways
are
also
discussed,
with
focus
on
specific
Finally,
this
analyzes
roles
modification
development
multiple
diseases,
offering
comprehensive
understanding
pathophysiology
these
conditions
proposing
new
directions
targets
treatment
strategies.